DRC-Funded Discovery Reaches Major Milestones

newsletter masts 54

This spring, Sana Biotechnology and Mayo Clinic announced a strategic collaboration to accelerate the development of SC451, an investigational stem cell-derived pancreatic islet cell therapy for type 1 diabetes. The […]

12 Month Update: Dr. Leonardo Ferreira

Leonardo Ferreira

This project focused on engineering primary human regulatory T cells (Tregs) with a chimeric antigen receptor (CAR) to create a therapy for type 1 diabetes (T1D). These CAR Tregs can […]

6 Month Update: Dr. Leonardo Ferreira

6 Month Project Update This project focuses on using HLA-A2 CAR Tregs to protect HLA-A2-expressing human pancreatic islets from rejection in a humanized model of T1D, which this DRC grant […]

6 Month Update: Chaita Rao

63 Chaitra Rao PhD

6 Month Update The primary objective of this DRC-funded project is to investigate the role of PD-L1 molecules in beta cells under stress conditions, hypothesizing that they may increase to […]

6 Month Update: Joanna Filipowska

62 Joanna Filipowska PhD

6 Month Update Our studies have identified a novel pathway consisting of two receptors, LGR4 (Leucine-rich repeat-containing G-protein-coupled receptor 4), a positive, and RANK (Receptor Activator of NFκB), a negative regulator, whose […]

6 Month Update: Aurelien Chuard

59 Aurelien Chuard PhD

6 Month Project Update Aim 1. Determine the viral infection history of T1D patients compared to healthy controls. Methods: We designed 15,000 oligonucleotides covering all 6 of the insulin carrying viruses […]

6 Month Update: Carmen De Miguel

60 Carmen De Miguel PhD

6 Month Project Update The goal of our pilot project is to identify the role that the G protein-coupled estrogen receptor (GPER) plays in the development and progression of kidney […]

Skip to content